To investigate micronutrient supply in phenylketonuria (PKU) patients on a relaxed diet. SUBJECTS/METHODS: Sixty-seven patients (6-45 years) with a phenylalanine tolerance X600 mg/day were included in the study. From a 3-day diet record, protein supply as well as consumption of essential amino acids and several micronutrients were assessed and compared with the current recommendations and data for the healthy population. RESULTS: Protein supply and consumption of all essential amino acids were sufficient in all patients. Supply of micronutrients depended on dietary regime. Patients with a total protein supply of 120% or more of the recommended amount and at least 0.5 g protein per kg body weight from amino-acid mixture (AAM) were sufficiently supplied with all investigated micronutrients. All patients without AAM supplement showed severe micronutrient deficiencies in their diet records. CONCLUSION: PKU patients under a relaxed diet are at risk of an insufficient nutrient supply, if they have first no substitution with AAM, second a protein supply less than 0.5 g per kg body weight from AAM or third a total protein supply less than 120% of the recommendations. Therefore, close monitoring, specific dietary counseling and potential supplementation is mandatory to prevent micronutrient deficiencies in PKU patients.
INTRODUCTION
Phenylketonuria (PKU; OMIN 261600) is one of the most common inborn metabolic disorders, with an incidence varying between 1:3000 and 1:30 000 across Europe. 1 It is caused by a deficient activity of phenylalanine hydroxylase (EC 1.14.16.1) in most tissues, predominantly in the liver. Children with untreated PKU suffer from severe physical and mental disability. Postnatal diagnosis by newborn screening, immediate initiation of a lifelong phenylalanine (Phe) restricted diet and supplementation of a Phe-free amino-acid mixture (AAM) result in a normal cognitive development. The individual daily Phe tolerance depends on residual phenylalanine hydroxylase activity and varies significantly between patients. 2 The necessary AAM dosage depends on the individual Phe tolerance, age and body weight. To account for metabolic imbalances and potential absorption deficiencies of amino acids from the AAM, it is generally suggested to provide an additional surplus of about 20% of the recommended protein supply. 3 To avoid micronutrient deficiencies, as the patients' choice of natural food is extremely limited, the AAM contain significant amounts of vitamins, minerals and trace elements. 4 Patients with a mild course of the disease who follow a relaxed diet require only a small amount of AAM. Consequently, these patients might be at risk of insufficient micronutrient supply.
PATIENTS AND METHODS

Study design
The study was planned and carried out as an open multicenter crosssectional investigation in patients with PKU with a Phe tolerance above 600 mg/day. The trial was performed in accordance with the Declaration of Helsinki/Somerset West and followed ICH-GCP guidelines. The protocol was reviewed and approved by the ethics committee of the University of Leipzig, Germany (registration number: 035-11-24012011), and has been registered with Deutsches Register Klinischer Studien at the International Clinical Trials Registry Platform (DRKS00004768). Patients and/or guardians were informed of the study in writing and gave their written consent.
Subjects and Methods
Inclusion was restricted to patients with PKU older than 6 years with a Phe tolerance above 600 mg/day. Patients were excluded who had additional diseases, abnormal results from the general or neurological examination, a need for concomitant medication except the Phe-free AAM, other dietary restrictions, or an existing or planned pregnancy. Anthropometric data (weight, height, body mass index) of the patients were collected at the clinic visit. Seventy-two patients were willing to join the study and sixty-seven met the inclusion criteria. All patients already participated in regular follow-up in a specialized outpatient center for inborn metabolic diseases (University Hospitals in Erlangen, Hamburg, Leipzig or Mü nster, all in Germany).
The patients were asked to provide a detailed 3-day diet record including all food, beverages and the AAM. From the records, the intake of Phe, energy, protein, carbohydrate, fat, essential amino acids, calcium, iron, zinc, iodine, vitamins B1, B2, B12, C, D and folic acid was calculated. Nutritional analysis was performed using the Food and Control Management System 'Diät-2000' based on the updated version of the German nutrient data base (Bundeslebensmittelschlü ssel). 5 Additional information provided by the manufacturers about low-protein food as well as pre-processed foods and the composition of the specific AAMs was added to the database. Intake of all macro-and micronutrients investigated was converted into a percentage of the recommendations issued by the German Society of Nutrition, according to age, body weight and gender. 4 To evaluate the intake of essential amino acids, in addition to total protein, the American recommendations 6 were used as reference values, as no German or European recommendations are currently available.
To retrieve comparable data for the healthy population, the data of two studies were used: EsKiMo 7 for the age group 6-17 years and the NVS II 8 for the age group above 17 years.
To analyze micronutrient intake, the patients were divided into two groups: group 1 represents patients who do not use an AAM, whereas group 2 represents patients receiving any AAM. Group 2 was further divided into two subgroups according to their total protein intake (group 2a with more and group 2b with less than 120% protein intake of the recommendations, Table 2 ). Yet another subdivision was done by the amount of protein from AAM. One group includes all patients with a protein intake from AAM less than 0.5 g per kg body weight (n ¼ 20) and the other group more than 0.5 g per kg body weight (n ¼ 34).
Statistical analyses
All statistical procedures were performed using SPSS for Windows 17 (SPSS Inc., Chicago, IL, USA). In order to reduce the number of variables, the mean of the three diet records was calculated for each variable and used for analyses. As data did not follow normal distribution, MannWhitney U-test was used to compare patient groups. If more than two groups were compared Kruskal-Wallis test was applied. To compare the patient's nutrient intake with the current recommendations, 4 the Wilcoxon test was used. A nominal level of Po0.05 was regarded as statistically significant.
RESULTS
Diet records from 67 patients were included into the analyses. Patients' characteristics are shown in Table 1 .
Of the 13 patients not using any AAM, 8 patients are under sapropterin therapy (Phe intake in mg: 1982, range 1205-2552). The other five patients are patients with mild hyperphenylalaninaemia and a relatively high residential enzyme activity (Phe intake in mg: mean 2473, range 1460-3626). All 13 are under continuous care in a specialized outpatient clinic. In patient group 2, 13 patients received sapropterin (Phe intake in mg, mean: 1442, range: 615-2606). The other 41 do not receive sapropterin. As in group 1, all patients in group 2 are under continuous care in a specialized outpatient clinic.
Almost all included patients show Phe concentrations within their age-specific target ranges, according to the German guidelines.
Intake of protein, Phe and essential amino acids The protein and Phe intake of the different groups are shown in Table 2 . Total protein intake was not significantly different for groups 1 and 2. However, Phe intake was significantly (P ¼ 0.006) lower in group 2, illustrating the patients' need for protein supply with AAM. The intake of essential amino acids exceeded the current recommendations in all patients (Figure 1 ), whether receiving an AAM (group 2) or not (group1).
The general recommendations for amino-acid intake do not distinguish between Phe and tyrosine, as healthy individuals convert sufficient amounts of Phe to tyrosine. This is not true for Abbreviations: AMM, amino-acid mixture; BMI, body mass index; SDS, standard deviation score. Anthropometric data of all included patients, grouping according to protein-and AAM intake. Group 1: patients without any AAM supply. Group 2: patients with AAM supply. Group 2a: patients with AAM supply and a total protein supply 4120% of the recommendations. Group 2b: patients with AAM supply and a total protein supply o120% of the recommendations. All data are given as mean ± s.d.
Micronutrient deficiencies in PKU on a relaxed diet C Rohde et al PKU patients and therefore the supply with tyrosine was calculated and compared with the combined Phe/tyrosine recommendation. Tyrosine supply alone exceeded the combined Phe/tyrosine recommendation in all groups (details not shown).
In addition, we assume that Phe supply was at least sufficient, because the patients' plasma Phe concentrations were not below the reference values (data not shown).
Intake of micronutrients Despite a sufficient supply of protein and essential amino acids, group 1 (no AAM supply) showed an insufficient supply with all investigated micronutrients, as compared with the current recommendations, 4 except for vitamin B 12 ( Figure 2 ). Even in comparison to the healthy population, patients in group 1 consumed smaller amounts of all micronutrients (Figure 2 ). In group 2 (any AAM supply), the intake of most micronutrients exceeded the current recommendations. For further analysis, group 2 was divided according to their total protein supply (2a4120%, 2bo120% of the recommendations). Group 2a was sufficiently provided with all micronutrients (Figure 2 In contrast, group 2b (total protein supply below 120% of recommendation) had an insufficient supply of most micronutrients (Figure 2) . However, the differences were not statistically significant except for vitamin B 2 (P ¼ 0.019) when compared with the recommendations. 4 There were no differences between children and adults. A positive correlation between the intake of protein from AAM in g per kg body weight and the intake of micronutrients could be detected for most micronutrients (vitamin D: r ¼ 0. Modeling a strategy for sufficient micronutrient supply When analyzing the data, patients with sufficient micronutrient supply appeared to consume protein from an AAM at a dose of 0.5 g per kg body weight or more. In order to test this hypothesis, we calculated the supply with micronutrients according to this threshold. Indeed, patients with a protein intake from AAM of at least 0.5 g per kg body weight (n ¼ 34, mean 0.8 ± 0.2 g protein per kg) showed significantly higher intake of vitamin D (Po0.001), calcium (Po0.001), iron (Po0.001), iodine (Po0.001), folic acid (Po0.001), vitamin B 1 (P ¼ 0.004) vitamin B 2 (Po0.001) and vitamin B 12 (Po0.001) than those patients with a protein intake of less than 0.5 g from AAM per kg body weight (n ¼ 20, mean 0.3±0.1). Moreover, the supply of all micronutrients exceeded the recommendations in those patients with at least 0.5 g protein per kg body weight from AAM: Vitamin C: 139% (P ¼ 0.022), vitamin D: 150% (Po0.001), vitamin B 1 :143% (Po0.001), vitamin B 2 : 146% (Po0.001), vitamin B 12 : 179% (Po0.001), folic acid: 155% (P ¼ 0.001), calcium: 151% (Po0.001), iron: 182% (Po0.001), zinc: 126% (P ¼ 0.166), iodine: 130% (Po0.001). Accordingly, the group with a protein intake from AAM of less than 0.5 g protein per kg body weight did not reach the recommendations for some micronutrients, especially folic acid (77%, P ¼ 0.006) and iodine (79%, P ¼ 0.007). However, these patients showed a significantly better supply of micronutrients compared with patients not consuming any AAM (vitamin D: Po0.001, vitamin B 1 : P ¼ 0.004, folic acid: Po0.001, calcium: Po0.001, iron: Po0.001, iodine: Po0.001).
DISCUSSION
To investigate the micronutrient supply in PKU patients with a high Phe tolerance (X600 mg/day), 69 patients from different metabolic centers in Germany were recruited. Diet records from three consecutive days were analyzed to evaluate the mean supply of protein, essential amino acids and several micronutrients. The intake of essential amino acids exceeded the current recommendations in all recruited patients. This was independent from the intake of any AAM. In contrast, supply of micronutrient was determined by the dietary regime. It is common use in PKU treatment to provide 120% of the protein supply recommended for healthy children, 3 in order to avoid potential metabolic imbalances. We therefore analyzed if application of this rule provides a sufficient supply of micronutrients. According to our analysis, this is clearly not the case. Patients not consuming any AAM were insufficiently supplied with micronutrients despite a median protein supply of over 150% of the recommendations. Patients receiving less than 120% of the recommended protein intake and less than 0.5 g protein per kg body weight from AAM are still at risk of micronutrient deficiencies. Micronutrient supply was sufficient only in the group with a total protein intake above 120% and more than 0.5 g protein per kg body weight from AAM. It can be expected that the number of PKU patients on a relaxed diet without AAM supplement will increase in the coming years because of the relatively new and successful cofactor therapy with tetrahydrobiopterin (BH 4 ) in patients with BH 4 -sensitive PKU. 9, 10 These patients are at risk of continuous micronutrient deficiencies with all known long-term consequences. [11] [12] [13] In general, basic eating habits develop during early childhood and remain stable throughout life.
14 In a previous study, we could show that patients who could relax their diet because of BH 4 sensitivity had difficulties to consume adequate amounts of meat and dairy products. 10 In this respect, ending the AAM supplementation in any PKU patient needs careful consideration, dedicated dietary counseling and close follow-up. It might be useful to provide these PKU patients with a specialized micronutrient mixture to bridge the time until their eating habits normalize toward sufficient micronutrient supply from natural sources. In this respect, the role of specialized dieticians in the care for PKU patients becomes ever more important.
Our data provide a good example of the persistence of unfavorable eating habits in PKU on a relaxed diet without AAM supply: the supply with vitamin C was lower than the DACHrecommendations and lower than the supply of the healthy population. This may be unexpected, as the main source of vitamin C is fruits and vegetables, which are low in protein and therefore appropriate for the PKU diet. Patients on a classical diet consume larger amounts of fruits and vegetables than their healthy peers. 15 However, this seems not to be true for patients with a high Phe tolerance: relaxing the diet because of increased Phe tolerance by addition of BH 4 led to decreased consumption of fruits and vegetables and consequently vitamin C supply. 10 Of concern, the intake of calcium and vitamin D is far below the recommendations, confirming earlier studies. 16 In a subgroup of 12 patients for whom plasma 25-OH-vitamin D was available, 9 showed concentrations at or below the lower limit of normal (mean ¼ 19 ng/ml; range ¼ 7.9-29.7), underlining the insufficient vitamin D supply. A clear relation to the intake of an AAM could not be found. Unfortunately, the sample size is too small to allow any further interpretation. A systematic evaluation of vitamin D intake and plasma concentrations with respect to amino-acid intake should be performed as a next step, and should include other factors contributing to vitamin D metabolism, such as latitude, habits influencing exposure to sunlight, skin color, use of sunscreen, etc. In the healthy population, bone density in adulthood is closely related to calcium and vitamin D consumption through cow's milk during childhood. [17] [18] [19] To account for the potential calcium and vitamin D deficiency in PKU because of the dietary restrictions, the currently available AAM contain calcium and vitamin D. This appears appropriate as long as patients consume enough AAM. Previous studies indicate reduced bone density in early and continuously treated classical PKU, even though these patients received both vitamin D and calcium in adequate amounts from AAM. 20, 21 There is only limited data on bone mineral density and metabolism in adult PKU and in particular those on a relaxed diet may be at increased risk of osteoporosis. As clinical monitoring of osteoporosis is difficult, bone densitometry may be an appropriate screening procedure in PKU, at least once in early adulthood. 22 Interestingly, irrespective of the group, vitamin B 12 was the only adequately consumed micronutrient. This is in contrast to previous studies which had shown that the supply with vitamin B 12 is critical in PKU patients, in particular in those patients following a relaxed PKU diet. [23] [24] [25] Vitamin B 12 and folate plasma concentrations were available from 23 patients, and all were within or above the normal range, irrespective of any AAM intake (vitamin B12: mean 390 pmol/l; range: 162-780 pmol/l; reference range: 141-489 pmol/l. Folate:445.4 nmol/ml in all patients). However, despite our data, regular assessment of vitamin B 12 and folate supply is recommended 26 as the clinical signs of vitamin B 12 or folate deficiency are unreliable indicators. 23, 25 Although the assessment of the supply of micronutrients usually proves to be difficult, 27, 28 we are confident that the detailed records provided by our patients reliably reflect true supply: PKU patients and their guardians are trained from the time of diagnosis to exactly weigh and document all food intake. 29 They are instructed to do so during the daily routine and monitored for it during the follow-up visits at the outpatient clinic. Those records do not show major differences over the year. In spite of accuracy of food documentation, the small amount of dietary records per patient is a limitation to the study.
In conclusion, a sufficient micronutrient supply in PKU patients with a protein supply below 120% of the recommendations is doubtful. The largely applied surplus of 20% of protein supply in the German speaking countries as well as the even higher protein supply for PKU patients in the United Kingdom 29 proves to guarantee a sufficient micronutrient supply, provided at least 0.5 g of protein per kg body weight derive from AAM. In those patients who do not require an AAM, we recommend to monitor micronutrient supply, to include the discussion about micronutrients in nutritional counseling and to supplement deficient components at least temporarily.
